Association of Circulating IgE and CML Levels with In-Stent Restenosis in Type 2 Diabetic Patients with Stable Coronary Artery Disease [PDF]
, 2022 Jingmeng Liu +12 more
openalex +1 more source
Evaluation of Off‐Label Postoperative Inhaled Steroid Use in Tracheal and Cricotracheal Resection
Otolaryngology–Head and Neck Surgery, Volume 174, Issue 2, Page 473-478, February 2026.Abstract Objective Tracheal resection (TR) and cricotracheal resection (CTR) are associated with anastomotic complications. Off‐label use of inhaled corticosteroids has gained popularity for reducing tracheal granulation tissue, though adoption remains limited due to unclear safety and efficacy.
Jason Shin Chwa +3 more
wiley +1 more source
European Journal of Case Reports in Internal MedicineIntracoronary in-stent restenosis (ISR) is a phenomenon that generally occurs between 3 and 6 months after stent placement. With the introduction of drug-eluting stents (DES), the incidence of ISR has decreased but not disappeared.
Benedetta Tomberli +5 more
doaj +1 more source
MedicinaBackground and objective: carotid artery stenosis contributes significantly to ischemic strokes, with management options including carotid endarterectomy (CEA) and carotid artery stenting (CAS) ischemic stroke risk can be reduced.
Agnė Gimžauskaitė +10 more
doaj +1 more source
Use of Paclitaxel-Coated Balloon Catheter Dilation to Reduce In-Stent Restenosis in Transjugular Intrahepatic Portosystemic Shunt (TIPS) [PDF]
, 2016 Stephan Rodrigo Marticorena Garcia +5 more
openalex +1 more source
Development of coronary stents using advanced results of materials science and technology [PDF]
, 2004 Stents are high tech endovascular implants. K&M Inc. is the single Eastern European stent producer company. The market needs more biocompatible devices as the trend of the stent development all the producers have to react.
Dobránszky, János +3 more
core
Restenosis risk factors after coronary stenting in metabolic syndrome patients
Кардиоваскулярная терапия и профилактика, 2007 This review is devoted to coronary restenosis after stent implantation in metabolic syndrome (MS) patients. It is known that some clinical factors increase restenosis risk, first of all, diabetes mellitus.
N. M. Danilov +3 more
doaj
Percutaneous Ureteric Stricture Dilation (PCUSD) [PDF]
, 1997 Ureteric stricture dilation as an interventional uroradiological technique was initiated locally in March 1991. In ureteric dilation two approaches are feasible.
Cutajar, Lino +4 more
core
The Role of Extracellular Matrix within the Neointima in A Porcine Coronary Stent Restenosis Model [PDF]
, 2003 Ok Young Park +12 more
openalex +1 more source
Fasting blood glucose predicts high risk of in-stent restenosis in patients undergoing primary percutaneous coronary intervention: a cohort study [PDF]
, 2023 Ge‐cai Chen +6 more
openalex +1 more source